Gene-Silencing Pesticides Pose New Risks to Health, Environment and Farmers
By Eva Sirinathsinghji, Kendra Klein and Dana Perls,
Friends of the Earth
| 10. 06. 2020
WASHINGTON — “Gene-silencing pesticides” now under development pose unique risks to surrounding ecosystems and beneficial insects, including bees, according to a new report, released today by Friends of the Earth and Dr. Eva Sirinathsinghji. The report summarizes the gaps in research on experimental gene-silencing pesticides and the risks they pose to human health, the environment, and farmers.
Several biotech and agrichemical companies are moving quickly to patent and bring gene-silencing pesticides to market. Corporations including Bayer [OTCMKTS: BAYRY], BASF [OTCMKTS: BASFY], and Syngenta [owned by Sinochem-ChemChina], are using genetic engineering to develop the new pesticide sprays that exploit a cellular process called RNA interference (RNAi), in order to switch off or “silence” genes that are essential for the survival of insects — thus killing them.
The first gene-silencing pesticide spray is slated to be submitted to the U.S. EPA for registration by the end of this year. The product, developed by GreenLight Biosciences, targets the Colorado potato beetle. The spray is designed to be applied to crop leaves. When a beetle eats the contaminated leaves, genetic material enters the...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...